Navigation Links
Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters
Date:9/22/2009

MOUNTAIN VIEW, Calif., Sept. 22 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced the launch of an expanded family of DAC(TM) neurovascular catheters. The DAC catheters are a first-in-class family of devices used to provide distal access and support in tortuous anatomy commonly encountered in stroke and other neurovascular procedures.

The original DAC catheter was launched in August 2008 as a distal access, support and delivery device for use in Merci Retriever procedures. The original product quickly gained favor in both Merci procedures and general neurovascular procedures. With this launch, Concentric expands the family of DAC catheters to include a full range of diameters and lengths.

Stanley L. Barnwell, M.D., Ph.D., Medical Director of Interventional Neuroradiology at Oregon Health and Science University in Portland, Oregon, said, "The DAC family of catheters provides access to parts of the neuroanatomy previously only accessible with smaller microcatheters. Their large inner diameters allow for the delivery of a variety of tools and therapies into the neurovasculature. I have found them to be particularly useful for support during intracranial angioplasty and stenting, and revascularization of acutely occluded arteries in the setting of acute stroke."

Maria Sainz, President and CEO of Concentric Medical, said, "We are very excited to bring a full family of neurovascular devices to the market. New product introductions have driven our success in the last year. Stroke remains an area of huge unmet need, and new technology brings significant value to clinicians caring for stroke patients. This recent launch caps a year of accelerated innovation at Concentric; over 70% of our sales in 2009 have been generated by products released within the last 12 months."

About Concentric Medical

Concentric Medical is located in Mountain View, California, and was founded in August 1999. The company manufactures and markets the Merci Retrieval System(R), which is a minimally invasive device delivered by a neurointerventionalist into the brain to restore blood flow by removing blood clots that cause ischemic stroke. The Merci Retrieval System is available in over 250 leading stroke centers around the world, and has been the subject of two successful clinical trials, MERCI and Multi MERCI. Concentric Medical estimates that over 10,000 patients have been treated with its devices. For more information about Concentric Medical, please visit www.concentric-medical.com.

    Media Contact: Mike Dineen, VP of Marketing
    +1 650-938-2100
    strokeinfo@concentric-medical.com


'/>"/>
SOURCE Concentric Medical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients
2. Concentric Launches New Consumer Division, Names Mike Devlin EVP, Managing Director
3. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
4. Maria Sainz Named President and CEO of Concentric Medical
5. Concentric Named to List of Top 60 Healthcare Agencies in U.S.
6. Concentric Medical Launches Distal Access Catheter
7. Concentric Medical Reaches Important Stroke Milestone
8. Concentric Medical Expands Product Offering in Neuro Access
9. Concentric Medical Announces Enrollment Milestone for Merci Registry
10. MSU engineering team designs innovative medical device
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... -centric training, today announced the launch of a new research study, The Business ... skills needed to execute that strategy, and the actual success of achieving individual ...
(Date:3/27/2017)... ... , ... According to the American Cancer Society , the average 15-year ... Once the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year ... this latter group, tune in to Lifestyle Magazine on April 9, 2017, ...
(Date:3/27/2017)... ... 2017 , ... Golden Triangle Emergency Center will be hosting ... to commemorate the two-year anniversary of the facility. The event will feature refreshments ... years while also familiarizing themselves with the facility. , In the two years ...
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease ... hospitals in the United States, it’s a threat that is constantly changing and ... infection prevention and offers strategies for the healthcare community to help decrease the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: